- Report
- March 2024
- 197 Pages
Global
From €3237EUR$3,374USD£2,788GBP
€3597EUR$3,749USD£3,098GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- March 2024
- 200 Pages
Global
From €3982EUR$4,150USD£3,430GBP
- Report
- October 2023
- 122 Pages
North America
From €4222EUR$4,400USD£3,636GBP
- Report
- February 2024
- 120 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Report
- May 2024
- 184 Pages
From €3237EUR$3,374USD£2,788GBP
€3597EUR$3,749USD£3,098GBP
- Report
- April 2023
- 144 Pages
Global
From €2830EUR$2,950USD£2,438GBP
- Report
- March 2018
- 118 Pages
Global
From €4078EUR$4,250USD£3,512GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,198GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,198GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,264GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,264GBP
- Report
- June 2021
- 120 Pages
Global
From €2399EUR$2,500USD£2,066GBP
- Report
- August 2022
United States
From €1861EUR$1,940USD£1,603GBP
- Report
- August 2022
Global
From €950EUR$990USD£818GBP
- Report
- August 2021
Europe
From €3281EUR$3,420USD£2,826GBP
- Report
- August 2021
Global
From €3828EUR$3,990USD£3,297GBP
- Report
- February 2021
Global
From €2840EUR$2,960USD£2,446GBP
Bone cancer is a type of cancer that affects the cells of the bones. It is a rare form of cancer, but can be very aggressive and difficult to treat. Oncology drugs are used to treat bone cancer, and can include chemotherapy, radiation therapy, and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while radiation therapy is used to shrink tumors. Targeted therapy drugs are designed to target specific molecules in cancer cells, and can be used in combination with other treatments.
The bone cancer drug market is a subset of the larger oncology drug market. It is a rapidly growing market, driven by the increasing prevalence of bone cancer and the development of new treatments. Companies in the bone cancer drug market include Novartis, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more